VEGFA and neoplasm: Physiological changes in the pregnant patient promote accelerated tumour growth with several theories proposed to explain this phenomenon: hormonal changes; increased levels of growth factors; angiogenic factors; and vascular endothelial growth factor have all been implicated [56].